The recent prevention guidelines issued by the American Heart Association and the American College of Cardiology became the center of some controversy during AHA's annual meeting, when word got out...
Far from reducing the risk of cardiovascular events in patients with recent acute coronary syndrome, the sPLA2 inhibitor varespladib actually raised the risk of MI in an international randomized...
Adding renal-artery stenting to comprehensive medical therapy did not confer significant benefit with respect to the prevention of clinical events in patients with atherosclerotic renal-artery...
A multifaceted intervention was effective for improving postdischarge medication adherence among patients hospitalized for acute coronary syndrome but had no effect on achievement of blood pressure...
SAN FRANCISCO – Transcatheter aortic valve replacement with the self-expanding CoreValve in patients at extreme surgical risk significantly reduced the rate of death or major stroke at 1 year, from...
ATLANTA – The combined use of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker was associated with an increased risk of hyperkalemia and acute kidney injury in patients...
The Food and Drug Administration has made a move toward further reducing – or eventually removing – the trans fat content in processed foods, with the "preliminary determination"...
In patients with restless legs syndrome, frequent leg movements during sleep were associated with the progression of atrial fibrillation, reported Dr. Mahek Mirza and her associates.
In their study,...
WASHINGTON – Treatment with nonselective beta-blockers was not associated with an increased mortality risk in patients with decompensated cirrhosis, judging from findings from a retrospective...
